Xijing Hospital

Running trials

• Not yet recruiting

  A Study of T-DXd in AI-Assessed HER2-Ultralow Metastatic Breast Cancer

  NCT07782086· Source

• Not yet recruiting

  Zanidatamab Combined With Chemotherapy as Neoadjuvant/Conversion Therapy for HER2-Positive (IHC 3+ or IHC 2+) Advanced Gastric or Gastroesophageal Junction Adenocarcinoma: a Phase II Open-Label Study

  NCT07685704· Phase 2· Source

• Recruiting

  Isatuximab-VRd in Transplant-Ineligible Newly Diagnosed Multiple Myeloma Patients

  NCT07663253· Source

• Not yet recruiting

  Pulsed Field Ablation Versus Radiofrequency Ablation: Effects of Pulmonary Vein Isolation Combined With Left Atrial Posterior Wall Isolation on Postoperative Gastric Motility in Patients With Persistent Atrial Fibrillation

  NCT07612241· Source

• Recruiting

  Diagnostic Value of the Liver Inflammation Index for MASH in Patients With T2DM and MAFLD

  NCT07632677· Source

• Recruiting

  Safety and Efficacy of S103 Cells in Progressive/Refractory Multiple Sclerosis

  NCT07587125· Phase 1· Source

• Not yet recruiting

  Efficacy and Safety of CD19 CAR-γδ T Cells in the Treatment of Relapsed/Refractory Autoimmune Nephropathy

  NCT07535138· Early phase 1· Source

• Recruiting

  Clinical Study on the Efficacy and Safety of LM-302 Injection Combined With Tislelizumab and Tislelizumab Combined Chemotherapy for the Treatment of Gastric or Gastroesophageal Junction Adenocarcinoma.

  NCT07385703· Phase 3· Source

• Recruiting

  Picankibart in Palmoplantar Pustulosis

  NCT07552454· Source

• Recruiting

  Phase Ⅲ Study of Efficacy and Safety of HSK39297 Tablet in Treatment of Patients With Primary IgAN

  NCT07390123· Phase 3· Source

• Recruiting

  Comparative Effectiveness of Upadacitinib vs Corticosteroids as First-Line Therapy for Acute Severe Ulcerative Colitis（UPFRONT）

  NCT07546097· Phase 4· Source

• Recruiting

  HARMONY Trial : To Evaluate a Therapeutic and Monitoring Device(NOVAtria System) for Heart Failure Management

  NCT07402239· Source

• Recruiting

  Plasma Exosomal RNA Signature for Prostate Cancer Bone Metastasis

  NCT07553754· Source

• Recruiting

  A Multicenter, Prospective Study on the Prognostic Value of PSMA PET in Patients With Newly Diagnosed, Treatment-naïve Prostate Cancer

  NCT07474142· Source

• Recruiting

  Early Neurovascular Decoupling Trajectories After Revascularization in Acute Ischemic Stroke

  NCT07405762· Source

• Not yet recruiting

  Nevus Removal vs. Conservative Treatment in Halo Nevus With Vitiligo: A Randomized Study

  NCT07307534· Source

• Active, not recruiting

  Exemption of SLNB After Neoadjuvant Therapy for Triple-negative and Her2-positive Breast Cancer

  NCT07498400· Source

• Recruiting

  Bioresorbable Sirolimus-eluting scaffold in de Novo Coronary Artery Lesions

  NCT07022587· Source

• Recruiting

  FIREFLY Trial: Fenofibrate Intervention---Randomized Evaluation in First-Line PBC Therapy

  NCT07296458· Phase 3· Source

• Enrolling by invitation

  Application of an AI-Based Health Management System in Long-Term Epilepsy Management in Rural Areas

  NCT07448233· Source

• Recruiting

  A Prospective, Interventional, Exploratory Study Evaluating the Efficacy of Small-Molecule Compound XJH05 Ointment in the Treatment of Plaque Psoriasis

  NCT07780929· Source

• Recruiting

  BDB-001 Phase III Trial in ANCA-Associated Vasculitis

  NCT07168161· Phase 3· Source

• Recruiting

  A Study of QL1706 Combined With Short-Cycle Anthracyclines or Taxanes for the Treatment of Early-Stage TNBC

  NCT07178171· Phase 1· Source

• Recruiting

  A Prospective, Single-arm, Open-label Clinical Trial to Evaluate the Efficacy and Safety of Ivarmacitinib in the Treatment of Palmoplantar Pustulosis

  NCT07270003· Source

• Recruiting

  Comparing the Components of Composite Endpoints for Healthcare Providers and Patients

  NCT07378137· Source

• Recruiting

  Study on the Preferences for PCI Implantation Devices Among Doctors and Patients

  NCT07378163· Source

• Not yet recruiting

  Temporal Interference for Temporal Lobe Epilepsy Under SEEG

  NCT07082101· Source

• Recruiting

  Effects of Transcranial Magnetic Stimulation After Endovascular Treatment for Acute Ischemic Stroke

  NCT06639360· Source

• Recruiting

  Long-term Safety and Efficacy of Sacral Nerve Stimulation in Patients With Ulcerative Colitis

  NCT07114159· Source

• Recruiting

  Liquid Biopsy Multi-Omics and Biomarker Development in Melanoma

  NCT07584291· Source

• Not yet recruiting

  Therapeutic Study of 177Lu-CTR-FAPI in Advanced Metastatic Digestive Malignancies

  NCT07014254· Source

• Recruiting

  Effect of a Pharmacist-led Multifaceted Intervention on Treatment Outcomes in Hypertensive Patients

  NCT06558877· Source

• Recruiting

  Investigating Multigene Methylation Dynamics in Treatment Response Surveillance for Gastric Cancer

  NCT06979895· Source

• Recruiting

  Investigating Multigene Methylation Dynamics in Treatment Response Surveillance for Esophageal Carcinoma

  NCT06979869· Source

• Recruiting

  Efficacy and Safety of Neoadjuvant Cadonilimab Plus High-Dose Recombinant Human Interferon α1b in Stage III/IV Melanoma.

  NCT07586904· Early phase 1· Source

• Recruiting

  A Study of AL2846 Capsule Versus Placebo in the Treatment of Advanced Radioiodine-Refractory Differentiated Thyroid Carcinoma

  NCT06860971· Phase 3· Source

• Recruiting

  PET/CT Imaging Study With Simultaneous Dual-nuclide Imaging Technique

  NCT06914427· Source

• Not yet recruiting

  Long Term Efficacy and Safety of TMS Targeting Cerebellum to Treat DRE

  NCT06832813· Source

• Active, not recruiting

  Fenofibrate in Subjects With Primary Biliary Cholangitis (PBC)

  NCT07104201· Early phase 1· Source

• Active, not recruiting

  Zoledronic Acid Combined With EC-T for Triple-Negative Breast Cancer

  NCT06876636· Source

• Recruiting

  Modified Tumor-free Techniques Operation to Cervical Cancer

  NCT06836869· Source

• Not yet recruiting

  Optimal LDL-C Target in High-risk Patients After PCI

  NCT06821711· Source

• Recruiting

  Investigation of the Correlation Between Polyamine Levels and Their Key Enzymatic Activities in Association With Inflammatory Bowel Disease Progression

  NCT06995170· Source

• Recruiting

  Exploring the Treatment Duration of PD-1 Neoadjuvant Therapy in Stage II-III dMMR Rectal Cancer

  NCT06613165· Source

• Enrolling by invitation

  A Multicenter, Randomized, Controlled Trial of Prednisone Combined With Ursodeoxycholic Acid in the Treatment of Primary Biliary Cholangitis With Moderate to Severe Interface Hepatitis Characteristics

  NCT06591468· Phase 2/3· Source

• Recruiting

  Assessment and Management of Multiple Drug Use in Elderly Chronic Disease Patients

  NCT07180368· Source

• Recruiting

  CPVI With Modified Linear Ablation Versus CPVI in Patients With Long-standing Persistent Atrial Fibrillation (SINUS)

  NCT06516822· Source

• Recruiting

  Exploratory Study With Parallel Controls on the Safety and Efficacy of Neoadjuvant Low Branched-Chain Amino Acid Diet in Combination With Anti-PD-1 Monoclonal Antibody for Stage III Melanoma

  NCT07586891· Source

• Recruiting

  Clinical Characteristics of Sleep Disorders in Patients With Ulcerative Colitis

  NCT06359808· Source

• Recruiting

  Fenofibrate in Combination With Ursodeoxycholic Acid in Primary Biliary Cholangitis: a Real World Study

  NCT06755541· Phase 3· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Prostate cancer7 recruiting
• Coronary artery disease6 recruiting
• Primary biliary cholangitis6 recruiting
• Ulcerative colitis6 recruiting
• Stroke5 recruiting
• Gastric and esophageal cancer4 recruiting
• Epilepsy3 recruiting
• Melanoma3 recruiting
• Atrial fibrillation2 recruiting
• Colorectal cancer2 recruiting
• Heart failure2 recruiting
• High blood pressure2 recruiting
• IgA nephropathy2 recruiting
• Neuroendocrine tumours2 recruiting
• ANCA-associated vasculitis1 recruiting
• Cervical cancer1 recruiting
• Childhood cancers1 recruiting
• Chronic kidney disease1 recruiting
• COPD1 recruiting
• Crohn's disease1 recruiting
• Fatty liver disease (MASLD/MASH)1 recruiting
• Kidney cancer1 recruiting
• Lung cancer1 recruiting
• Lupus (SLE)1 recruiting
• Metastatic breast cancer1 recruiting
• Multiple myeloma1 recruiting
• Multiple sclerosis1 recruiting
• Obesity1 recruiting
• Pancreatic cancer1 recruiting
• Parkinson disease1 recruiting
• Psoriasis1 recruiting
• Thyroid cancer1 recruiting
• Triple-negative breast cancer1 recruiting
• Type 2 diabetes1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Completed

  Effect of Preoperative Stellate Ganglion Block on Postoperative Atrial Fibrillation After Coronary Artery Bypass Grafting

  NCT07271615· Source

• Completed

  A Pilot Study of Fenofibrate and Ursodeoxycholic Acid in the Treatment of Newly Diagnosed Primary Biliary Cholangitis

  NCT06591455· Early phase 1· Source

• Completed

  Optimizing Early Nutrition Support in Severe Stroke-2

  NCT05998902· Phase 3· Source

• Completed

  Effectiveness and Safety of Upadacitinib for Acute Severe Ulcerative Colitis

  NCT07472309· Source

• Completed

  The Mechanism of cTBS Targeting Dentate Nucleus for DRE

  NCT05809349· Source

• Completed

  Individualized dlPFC-NAcc Modulation for Anhedonia in adMDD

  NCT05544071· Source

• Completed

  Liver Resection for Patients With Hepatocellular Carcinoma and Impaired Liver Function

  NCT06245785· Source

• Completed

  Liver Resection for Patients With Hepatocellular Carcinoma and Clinically Significant Portal Hypertension

  NCT06245798· Source

• Completed

  Effects of Minocycline on Patients With Ischemic Stroke Undergoing Intravenous Thrombectomy

  NCT05487417· Phase 4· Source

• Completed

  Efficacy and Safety of Substitution of Glucocorticoid for BDB-001 Injection in Patients With Anti-neutrophil Cytoplasmic Antibody(ANCA)-Associated Vasculitis

  NCT05197842· Phase 1/2· Source

• Completed

  Percutaneous Intramyocardial Septal Radiofrequency Ablation for Obstructive Hypertrophic Cardiomyopathy in Children

  NCT06540183· Source

• Completed

  Image Fusion of SPECT MPI and Fluoroscopy Venography to Guide LV Lead Placement for Improved CRT Response (GUIDE-CRT II)

  NCT03125720· Source

Trial sites

• Department of Dermatology, Xijing Hospital, Air Force Medical University1 trial
• Department of Dermatology, Xijing Hospital, Fourth Military Medical University, No. 127 of West Changle Road, 710032, Xi'an, Shaanxi, China1 trial
• Department of Neurology, Xijing Hospital1 trial
• Department of Neurology, Xijing Hospital, Air Force Medical University2 trials
• Department of Neurology, Xijing Hospital, Fourth Military Medical University2 trials
• Department of Nuclear Medicine,Xijing Hospital, Fourth Military Medical University1 trial
• Department of Nuclear Medicine,Xijing Hospital, Fourth Military Medical University, Xi'an, China, Xi'an, Shaanxi Province Recruiting1 trial
• Xijing hospital58 trials
• Xijing Hospital, Air Force Medical University Xi'an, Shaanxi, China1 trial
• Xijing Hospital, Fourth Military Medical University2 trials
• Xijing Hospital /ID# 2107081 trial
• Xijing Hospital /ID# 2386501 trial
• Department of Endocrinology and Metabolism, Xijing Hospital, Air Force Medical University1 trial
• The Fourth Military Medical University, Xijing Hospital1 trial
• Xijing Hospital, Air Force Medical University7 trials

Conditions

Diseases this institution publishes on or runs trials for.

• Gastric and esophageal cancer46 works · 4 trials
• Psoriasis46 works · 1 trials
• Ulcerative colitis25 works · 8 trials
• Depression22 works · 1 trials
• Atopic dermatitis (eczema)18 works · 0 trials
• Primary biliary cholangitis7 works · 9 trials